Less than a third of ED visits for acute sickle cell disease pain were guideline-adherent for the timely administration of ...

ORLANDO — Rusfertide, a weekly self-injected peptide, maintained control of hematocrit levels and reductions in phlebotomy ...

Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical ...

The results of the 2025 Medicine and Pediatric Specialties Match followed the same patterns seen in recent years for both ...

Compared to hypofractionated radiotherapy, SBRT improves short-term but not long-term QoL in patients with inoperable stage I ...

Advocacy is needed now more than ever to improve pediatric care, particularly for subspecialties like rheumatology, given all the pressures accumulating on the field, Dr Madelaine Feldman writes.

A majority — eight members — voted that women who have tested negative for hepatitis B should consult with clinicians on when ...

Lisocabtagene maraleucel (liso-cel) is now the only CD19-directed chimeric antigen receptor (CAR) T-cell therapy approved for MZL. The approval marks liso-cel’s fifth indication, the most of any ...

Dr S. Shahzad Mustafa discusses three FDA approved medications for chronic spontaneous urticaria and the need to tailor ...

A retrospective real-world study strengthens evidence that early, sustained treatment with the antiamyloid lecanemab can slow ...

A deep analysis of semaglutide’s phase 3 AD trials shows no cognitive or functional benefit despite biomarker gains, yet ...

NICE has conditionally approved seven digital platforms for cardiac rehabilitation, aiming to expand access and improve participation across the NHS.